Aktis Oncology, Inc. (AKTS) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Aktis Oncology, Inc. (AKTS): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 24/100 — a percentile rank of Aktis Oncology, Inc.’s fundamentals against Manufacturing peers, weakest on management. A quality ranking, not a price prediction.
| Gross margin | 47.8% |
| Operating margin | -502.5% |
| Net margin | -733.7% |
| ROIC | -26.8% |
| Revenue growth | -28.0% |
Independent of the events above — derived from Aktis Oncology, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact